查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1796684

熊去氧膽酸API市場報告：至2031年的趨勢、預測與競爭分析

Ursodeoxycholic Acid API Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球熊去氧膽酸原料藥市場前景光明，這得益於醫藥和保健品市場的機會。預計2025年至2031年期間，全球熊去氧膽酸原料藥市場的年複合成長率將達到11.2%。推動該市場發展的關鍵因素包括肝病盛行率的上升、熊去氧膽酸在膽結石治療中的應用日益廣泛以及醫療保健支出的不斷成長。

  • Lucintel 預測，依產品類型分類，合成 UDCA 預計將在預測期內實現高速成長，因為它具有大規模生產的能力。
  • 從應用角度來看，由於肝病治療需求的不斷增加，藥局預計將出現高速成長。
  • 依地區分類，由於醫療保健投資的增加，預計亞太地區將在預測期內實現最高成長。

熊去氧膽酸API市場的新趨勢

肝病治療需求的不斷變化、製藥技術的進步以及永續生產的推進，改變產業的運作方式，熊去氧膽酸原料藥市場也未能倖免。以下是影響市場的五大趨勢。

  • 創新部門顯著成長：熊去氧膽酸現有用途的研發創新架構比以往更廣泛。例如，生產商現在不僅將非酒精性脂肪肝（NAFLD），還將肝纖維化納入其肝病治療範圍。這促進了熊去氧膽酸新劑型的研發競爭，並最終促進了新的業務拓展。進一步整合研發系統將有助於區分熊去氧原料藥與其他肝病治療藥物，並改善患者預後。
  • 製造業的永續性：市場對環保生產方法的需求日益成長，熊去氧膽酸原料藥的生產也是如此。製造商採用綠色技術，以最大限度地減少廢棄物、節約用水並減少二氧化碳排放，減少對環境的影響。永續生產在製藥業也日益受到關注。隨著監管要求的不斷提高以及消費者對環保生產方法的期望不斷提高，熊去氧膽酸製造商被迫與時俱進。
  • 製劑進展：緩釋性和緩釋性熊去氧膽酸等新型先進製劑的推出代表了產業的新趨勢。此類製劑不僅能更有效地幫助患者堅持治療，療效也更佳。肝病治療的進步也為熊去氧膽酸原料藥生產商帶來了標靶給藥的巨大潛力。
  • 新興地區需求成長：印度、中國和東南亞等市場肝病盛行率的上升推動了對熊去氧原料藥的需求。隨著醫療基礎設施的改善以及尋求肝病治療的人數不斷增加，對經濟實惠且有效治療方法的需求也日益成長。為了滿足這些市場日益成長的需求，製造商正將重點轉向以更低的價格生產熊去氧原料藥，推動市場成長。
  • 有利於肝病治療的法規：許多國家製定並實施市場友善政策，以支持肝病藥物的研發和批准。各國政府和監管機構透過為熊去氧膽酸等藥物提供獎勵和加速核准來應對日益加重的全球肝病負擔。這項措施有助於製造商在某些市場快速分銷熊去氧原料藥。

這些新興趨勢，包括對研發、永續性、精細藥物配方的日益重視、熊去氧原料藥帶來的新市場吸引力以及有利的政策環境，為熊去氧原料藥市場帶來新的機會和挑戰。這種轉變有望推動市場朝著更永續、創新和以患者為中心的參與解決方案發展。

熊去氧膽酸API市場的最新趨勢

熊去氧膽酸原料藥市場經歷顯著變化，這將影響其當前和未來的前景。這些變化源於技術進步、政策變化以及對熊去氧膽酸其他潛在治療用途研究的日益重視。以下列出了五個顯著變化：

  • 製造技術的進步：製造業採用更先進的生產實踐也推動了熊去氧膽酸API市場的發展。自動化生產流程的引進，例如連續生產和其他先進的純化方法，促進了高品質低成本熊去氧原料藥的生產。這些發展使生產商能夠滿足日益成長的國際需求，同時維持全球品質標準。
  • 聚焦非酒精性脂肪性肝炎（NASH）：隨著公共和私人部門在製藥公司研發上的投入不斷增加，非酒精性脂肪性肝炎（NASH）和其他肝病領域尚未得到滿足的需求也隨之增加。熊去氧膽酸在治療 NASH、B型肝炎和其他疾病方面的潛力也越來越受到關注。隨著研發工作的持續推進，熊去氧原料藥需求也將隨之成長。
  • 現有藥物用途的新核准：允許核准現有藥物新用途的法規凸顯了熊去氧膽酸類產品的市場發展。相關部門批准熊去氧膽酸用於治療更廣泛的肝病，拓寬其治療範圍。各公司正致力於開發熊去氧膽酸製劑，以加速其市場拓展。
  • 轉向更環保的生產方式：為了應對環境問題和監管關注，越來越多的熊去氧膽酸原料藥製造商轉向更環境永續的生產方式。這些舉措包括減少廢棄物、轉向更有效率的能源策略以及在化學製程中使用更少的有害物質。這些措施使熊去氧膽酸原料藥製造商能夠為環境保護做出貢獻，並滿足各種國際永續性標準。
  • 透過合作拓展市場：與其他市場一樣，製藥公司與研發機構之間的策略聯盟在熊去氧原料藥業務中變得越來越重要。這些聯盟有助於增強協同效應，進而開發熊去氧膽酸的新劑型和新治療用途。同時，這些聯盟也改善了熊去氧原料藥的國際分銷，使其能夠覆蓋更多新興國家。

技術進步、研發投入增加、津貼以及永續性措施是UCDA API市場的一些正面面向。創新、業務效率以及新治療適應症的開發是製造商關注的重點，目的是利用這一趨勢並滿足日益成長的全球需求。

目錄

第1章 執行摘要

第2章 市場概述

  • 背景和分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 熊去氧膽酸API市場（依類型）

  • 概述
  • 依類型的吸引力分析
  • 合成UDCA：趨勢與預測（2019-2031）
  • 提取的UDCA：趨勢和預測（2019-2031）

第5章 熊去氧膽酸API市場（依應用）

  • 概述
  • 依用途的吸引力分析
  • 製藥業：趨勢與預測（2019-2031）
  • 健康產品：趨勢與預測（2019-2031）

第6章 區域分析

  • 概述
  • 熊去氧膽酸API市場（依地區）

第7章 北美熊去氧膽酸API市場

  • 概述
  • 北美熊去氧膽酸API市場（依類型）
  • 北美熊去氧膽酸API市場（依應用）
  • 美國熊去氧膽酸原料藥市場
  • 墨西哥熊去氧膽酸API市場
  • 加拿大熊去氧膽酸API市場

第8章 歐洲熊去氧膽酸原料藥市場

  • 概述
  • 歐洲熊去氧膽酸API市場（依類型）
  • 歐洲熊去氧膽酸API市場（依應用）
  • 德國熊去氧膽酸API市場
  • 法國熊去氧膽酸API市場
  • 西班牙熊去氧膽酸API市場
  • 義大利熊去氧膽酸API市場
  • 英國熊去氧膽酸API市場

第9章 亞太地區熊去氧膽酸API市場

  • 概述
  • 亞太熊去氧膽酸API市場（依類型）
  • 亞太熊去氧膽酸API市場（依應用）
  • 日本熊去氧膽酸原料藥市場
  • 印度熊去氧膽酸API市場
  • 中國熊去氧膽酸原料藥市場
  • 韓國熊去氧膽酸原料藥市場
  • 印尼熊去氧膽酸API市場

第10章 其他地區熊去氧膽酸API市場

  • 概述
  • 世界其他地區熊去氧膽酸API市場（依類型）
  • 世界其他地區熊去氧膽酸API市場（依應用）
  • 中東熊去氧膽酸API市場
  • 南美熊去氧膽酸API市場
  • 非洲熊去氧膽酸API市場

第11章 競爭分析

  • 產品系列分析
  • 運作整合
  • 波特五力分析
    • 競爭敵對
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市場佔有率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 依類型分類的成長機會
    • 依應用分類的成長機會
  • 熊去氧膽酸API市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業的公司簡介

  • Competitive Analysis
  • ICE
  • Mitsubishi Tanabe Pharma
  • Daewoong Chemical
  • PharmaZell
  • Zhongshan Bailing
  • Dipharma Francis
  • Grindeks

第14章 附錄

  • 圖表目錄
  • 表格列表
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於
  • 詢問

The future of the global ursodeoxycholic acid API market looks promising with opportunities in the pharmacy and health product markets. The global ursodeoxycholic acid API market is expected to grow with a CAGR of 11.2% from 2025 to 2031. The major drivers for this market are the increasing prevalence of liver diseases, the rising adoption of ursodeoxycholic acid for treating gallstones, and the growing healthcare spending.

  • Lucintel forecasts that, within the type category, synthetic UDCA is expected to witness higher growth over the forecast period due to its large-scale production.
  • Within the application category, pharmacy is expected to witness higher growth due to the increasing demand for liver disease treatments.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period due to the rising healthcare investments.

Emerging Trends in the Ursodeoxycholic Acid API Market

The constant changes in the demand for liver disease treatments, the growth of pharmaceutical technology, and the movement toward sustainable manufacturing are shifting how the industry works, and the ursodeoxycholic acid API market is not off the hook either. Given these observations, take a look at five trends affecting the market.

  • Alarming Growth in the Innovation Arms: The innovation towers of R&D for the existing application of ursodeoxycholic acid are wider than before. For example, the producers are looking beyond NAFLD and include hepatic fibrosis in the liver disease list. This constitutes a phenomenon that stimulates competition toward the creation of new formulations of ursodeoxycholic acid and hence new business expansions. Further integration into the R&D systems will be beneficial for the differentiation of the ursodeoxycholic acid APIs from those used in other liver disorders and for the enhancement of treatment outcomes for patients.
  • Sustainability in Manufacturing: There is a growing market with a demand for eco-friendly practices, and the production of ursodeoxycholic acid APIs is no different. Manufacturers are adopting green technologies that have less of an environmentally degrading effect, including waste minimization, water conservation, and reduction of carbon emissions. Even in the pharmaceutical industry, sustainable production is being given a lot of attention. With regulatory demands and consumer expectations for environmentally friendly practices, ursodeoxycholic acid manufacturers have no option but to move with the trends.
  • Advancements in Drug Formulations: The introduction of new sophisticated drug formulations like slow-release and sustained-release ursodeoxycholic acid-based drugs is a mark of the new trend of the industry. Such drug formulations would not only be more effective in enabling patients to comply with treatment but also more effective therapeutically. Improvements in liver disease treatment also provide great potential for targeted drug delivery promises for ursodeoxycholic acid API producers.
  • Increased Demand from Emerging Regions: The pace rising prevalence of liver diseases in markets like India, China, and Southeast Asia is boosting the demand for ursodeoxycholic acid APIs. With the improvement in healthcare infrastructure and an increasing number of individuals seeking treatment for liver disorders, the need for affordable and effective therapies is on the rise. Manufacturers are shifting their focus to produce ursodeoxycholic acid APIs at lower prices to meet the rising demand in these markets, thereby propelling the growth of the market.
  • Favorable Regulations about Liver Disease Treatment: A number of countries are trying to establish and implement policies that are friendly for the market in the purpose or aid the research, development, and approval of new liver disease treatment options. Governments and regulators have responded to the increase in the global burden of liver diseases by incentivizing and providing fast-track approval for drugs like ursodeoxycholic acid. This phenomenon is assisting in the rapid distribution of ursodeoxycholic acid APIs in several markets, which helps the manufacturers.

These emerging trends, which include R&D focus, sustainability, sophisticated drug formulation, new market drives from ursodeoxycholic acid APIs, and favorable policy setup, are transforming the ursodeoxycholic acid API market by providing new opportunities along with challenges to the manufacturers. The shifts are likely to push growth towards more sustainable, innovative, and patient-centric engagement solutions.

Recent Developments in the Ursodeoxycholic Acid API Market

There are notable changes in the market for Active Pharmaceutical Ingredient of Ursodeoxycholic Acid (ursodeoxycholic acid) that are affecting its present and future landscape. These changes are due to improved technology, changes in policies, and increased focus on research regarding other potential therapeutic uses of ursodeoxycholic acid. Given below are five notable changes:

  • Advances in Production Technology: Adoption of better production methods in manufacturing industries is also helping the ursodeoxycholic acid API market. The introduction of automated techniques in production processes, like continuous manufacturing and other advanced methods of purification, has produced high-quality, but low-cost ursodeoxycholic acid APIs. These developments have allowed producers to maintain the growing global quality standards while meeting the increasing international demand.
  • Focus on Non-Alcoholic Steatohepatitis (NASH): The increased spending both in public and private sectors on research and development by pharmaceutical companies is fueling the unmet needs of nonalcoholic steatohepatitis (NASH) and other liver diseases. There is an increasing focus on exploring the potential of ursodeoxycholic acid for treating conditions like NASH and hepatitis B. It is anticipated that with the increasing efforts in research and development, the scope of usage for ursodeoxycholic acid will increase along with the demand for its APIs.
  • New Approval for Using Existing Drugs: The regulations that allow for the approval of new uses for existing drugs highlight the progress made in the market for ursodeoxycholic acid-based products. The use of ursodeoxycholic acid for the treatment of a wider scope of liver diseases is being granted by the governing authorities, which is broadening its therapeutic scope. With attempts by marketing ursodeoxycholic acid-based products, the companies are trying to comply with them so that they can accelerate the development of new formulations of ursodeoxycholic acid drugs.
  • Efforts Towards Even More Environmentally Friendly Production: There is an increasing number of ursodeoxycholic acid API manufacturers that, in light of heightened eco-friendly concern and regulatory attention, have started to produce in a more environmentally sustainable manner. Such actions may involve decreasing the amount of waste, changing energy strategies to more efficient ones, and using less hazardous substances for the chemical processes. These activities will allow the manufacturers of the ursodeoxycholic acid API to contribute to the care of the environment and help them meet various international standards of sustainability.
  • Market Expansion through Collaborations: As it is in other markets, the strategic partnering of pharmaceutical firms with research and development institutions has been progressively more important in the ursodeoxycholic acid API business. Such collaborations facilitate the consolidation of synergies in the creation of new formulations and therapeutic uses of ursodeoxycholic acid. At the same time, these collaborations are improving the international distribution of ursodeoxycholic acid APIs to make them available in more developing countries.

Aspects such as enhanced technologies, growing investments into R&D, grants, and sustainability measures are UCDA API market forces looking in the forward direction. Innovation, operating efficiency, and creating new therapeutic indications are the focuses of the manufacturers to take advantage of the phenomena and satisfy the increasing global needs.

Strategic Growth Opportunities in the Ursodeoxycholic Acid API Market

Several strategic growth prospects exist in the application of the ursodeoxycholic acid API, which is simultaneously and operationally utilized in different spheres. The same is augmented due to the increased need for liver disease treatments, technological innovations, and growth of other pharmaceutical markets. These include but are not limited to these five opportunities:

  • Increasing Application in Liver Disease Conditions: With the increase in the number of people suffering from liver diseases, there is a great potential for improvement of ursodeoxycholic acid APIs in PBC, fatty liver disease, and cirrhosis. As the focus on the management of liver diseases increases, there is a corresponding increase in the need for drugs based on ursodeoxycholic acid. Hence, this factor largely increases the growth of UDC APIs.
  • Concentrating on Emerging Markets: Ursodeoxycholic acid API producers stand to gain enormously from newly industrialized regions in Asia and Africa. The demand for affordable treatment options is estimated to rise as the healthcare infrastructure improves and there is an increase in the awareness of liver diseases. To serve these emerging markets, manufacturers are looking to provide cost-effective ursodeoxycholic acid APIs.
  • Tackling Non-Alcoholic Fatty Liver Disease (NAFLD): The rising obesity rates and the growing occurrence of NAFLD is a huge opportunity for the growth of ursodeoxycholic acid APIs. There are ongoing studies that aim to assess the efficacy of ursodeoxycholic acid in the treatment of NAFLD, and with the advancement of clinical trials, this could possibly create a new market segment for drugs based on ursodeoxycholic acid.
  • Innovative Systems of Drug Delivery: The development of new systems of drug delivery, particularly sustained release and oral dosage forms, provides a unique opportunity for growth with ursodeoxycholic acid APIs. Increased patient adherence coupled with improved therapeutic efficacy from these systems will undoubtedly increase the use of ursodeoxycholic acid-based treatments.
  • Market Expansion by Collaboration and Partnerships: The merging of manufacturers, research centers, and healthcare facilities allows for the strategic marketing of the ursodeoxycholic acid API on an international scale. Involving other stakeholders in the pharmaceutical supply chain facilitates manufacturers in product development, distribution, and access to international markets.

These partnerships along with innovations in drug delivery, treatment expansion in emerging markets, and focus on NAFLD, offer the strategic growth opportunities that are likely to foster the future of the ursodeoxycholic acid API market. Those manufacturers who pursue them will reap the benefits of a well-established position in the long term.

Ursodeoxycholic Acid API Market Driver and Challenges

Like many other markets, the ursodeoxycholic acid API market is being driven and challenged by many factors which influence its growth. Also featured are new technological developments, increasing treatment needs for liver diseases, and the many facets of liver disease regulatory scope. Five drivers and three different challenges are provided below.

The factors responsible for driving the ursodeoxycholic acid API market include:

1. Rising Prevalence of Liver Diseases: Cirrhosis, NAFLD, PBC, and other liver disorders and their increasing prevalence globally is one of the key drivers of the ursodeoxycholic acid API market. More people being diagnosed with liver disorders leads to an increased need for medical attention, which results in higher consumption of drugs based on ursodeoxycholic acid. This helps in the growth of the market.

2. Advancements in Pharmaceutical Manufacturing: Continuous manufacturing, streamlined purification processes, and other advanced manufacturing technologies are creating better and less expensive ursodeoxycholic acid APIs. Increased efficiency and scalability of production positively impact the market.

3. Support from the Government for Liver Disease Treatments: New treatments for liver disease, such as those which utilize ursodeoxycholic acid, are getting assistance from governments and regulatory bodies across the world. The growth of the ursodeoxycholic acid API market is driven by the quick approval processes and subsidies for liver disease therapies.

4. Greater Focus on Healthcare: Demand for medicines that use ursodeoxycholic acid is growing due to increased awareness of the treatment and prevention of liver disease. As people become more educated on maintaining their liver health, the willingness to seek medical attention rises, which benefits the ursodeoxycholic acid API market.

5. More Funding in R&D Activity: There is a large investment from within the pharmaceutical industry in research and development to find new therapeutic uses of ursodeoxycholic acid. The market is being expanded by this investment through the introduction of new indications and improvement of the effectiveness of the ursodeoxycholic acid-based treatments.

Challenges in the ursodeoxycholic acid API market are:

1. Barriers in Regulation: The multi-step and tedious regulatory approval process for new drugs, including those that are ursodeoxycholic acid-based, can be difficult for manufacturers to navigate. Regulatory hurdles tend to delay the introduction of new products into the market, which restricts growth.

2. Price Sensitivity in Emerging Markets: Growing price sensitivity in emerging markets poses a problem for ursodeoxycholic acid API manufacturers. The limited spending of healthcare systems in these parts of the world could make it difficult for manufacturers to profitably provide affordable ursodeoxycholic acid-based drugs.

3. Patent Expirations and Generic Competition: Generic manufacturers are increasingly competing with original developers due to the expiration of patents for ursodeoxycholic acid-based drugs. While this competition drives the price of ursodeoxycholic acid-based treatments down, it also makes it harder for original developers to retain their market share.

The market for ursodeoxycholic acid APIs is subjected to the increase in liver diseases, new technologies, favorable regulations, growth in healthcare awareness, and R&D spending, but also to the continuous regulatory burden in the United States, sensitivity to pricing, and competition from generic drugs. Manufacturers have to find ways to deal with these issues if market growth and other challenges are to be met successfully.

List of Ursodeoxycholic Acid API Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leveraging integration opportunities across the value chain. With these strategies, ursodeoxycholic acid API companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ursodeoxycholic acid API companies profiled in this report include:

  • ICE
  • Mitsubishi Tanabe Pharma
  • Daewoong Chemical
  • PharmaZell
  • Zhongshan Bailing
  • Dipharma Francis
  • Grindeks

Ursodeoxycholic Acid API Market by Segment

The study includes a forecast for the global ursodeoxycholic acid API market by type, application, and region.

Ursodeoxycholic Acid API Market by Type [Value from 2019 to 2031]:

  • Synthetic UDCA
  • Extraction UDCA

Ursodeoxycholic Acid API Market by Application [Value from 2019 to 2031]:

  • Pharmacy
  • Health Products

Ursodeoxycholic Acid API Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Ursodeoxycholic Acid API Market

This ursodeoxycholic acid API market is influenced by ongoing innovation in the pharmaceutical sector, growth in the liver disease treatment market, and increasing knowledge about the advantages of ursodeoxycholic acid. Some areas like the US, China, Germany, India, and Japan are showing marked changes in the ursodeoxycholic acid market. Improvement in manufacturing procedures, approved regulations, and growing numbers of clinical studies are factors contributing to growth in the market. A summary of the recent progress in the ursodeoxycholic acid API market of these countries is outlined below.

  • United States: The United States is showing positive growth trends because of the growing number of liver diseases such as primary biliary cirrhosis (PBC). The demand for these drugs is increasing with the approval of ursodeoxycholic acid-based therapies for different liver disorders. Now, there is also an increasing emphasis on developing more sophisticated UCDA formulations. The quality and price of the APIs are also being enhanced by the manufacturers, resulting in better penetration of ursodeoxycholic acid-based therapies in the market. In addition, clinical research and trials are actively conducted in the area with encouraging results showing potential for treating other liver conditions, which is fueling market growth.
  • China: Known for its unrivaled production capabilities and low-cost manufacturing, China has emerged as a world leader in the ursodeoxycholic acid API market. There is growing demand for ursodeoxycholic acid in China due to the improving healthcare system and increasing number of patients seeking treatment for liver diseases. The support by the Chinese government's policies for the pharmaceutical sector also greatly improves access to quality ursodeoxycholic acid APIs. Additionally, China's position in the ursodeoxycholic acid API market is being strengthened by the increasing number of clinical trials and research activities in the region, along with the adoption of new advanced manufacturing technologies.
  • Germany: In Germany, the demand for ursodeoxycholic acid APIs is driven by advancements in the pharmaceutical sector. There is also a growing number of patients being diagnosed with liver diseases. The robust healthcare system in Germany, along with a high level of new drug utilization, drives the use of ursodeoxycholic acid medications. The German government also facilitates treatment innovation for liver diseases within the country. There is also an increase in R&D activities in Germany aimed at optimizing the ursodeoxycholic acid formulations and developing new therapeutic uses, and this is also contributing to market growth.
  • India: The increasing demand for ursodeoxycholic acid APIs in India stems from both the growth of the healthcare sector and the rising cases of liver disorders in the country. There is ursodeoxycholic acid API production in India offered at competitive prices and of high quality to meet the global market demand. The Indian pharmaceutical industry is also funding R&D for enhanced formulations of ursodeoxycholic acid and other liver disease therapeutics. Growth in population awareness and the country's improved healthcare accessibility are further expected to drive the rise in ursodeoxycholic acid API sales in India.
  • Japan: The ursodeoxycholic acid API market in Japan is continuously growing, which is largely attributed to the aging population and the high prevalence of liver diseases in the country. There is wide usage of ursodeoxycholic acid and cholic acid in Japan for liver disorder treatment, and the demand for better formulations is on the rise. Japanese pharmaceutical manufacturers are dedicated to using high-grade manufacturing equipment to produce superior quality ursodeoxycholic acid APIs in order to meet the stringent regulatory requirements in Japan. Moreover, the increase of Japan's investment into health R&D will most likely increase the use of ursodeoxycholic acid APIs, especially for chronic liver diseases.

Features of the Global Ursodeoxycholic Acid API Market

  • Market Size Estimates: Ursodeoxycholic acid API market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Ursodeoxycholic acid API market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Ursodeoxycholic acid API market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the ursodeoxycholic acid API market.
  • Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the ursodeoxycholic acid API market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ursodeoxycholic acid API market by type (synthetic UDCA and extraction UDCA), application (pharmacy and health products), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Ursodeoxycholic Acid API Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Synthetic UDCA: Trends and Forecast (2019-2031)
  • 4.4 Extraction UDCA: Trends and Forecast (2019-2031)

5. Global Ursodeoxycholic Acid API Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Pharmacy: Trends and Forecast (2019-2031)
  • 5.4 Health Products: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Ursodeoxycholic Acid API Market by Region

7. North American Ursodeoxycholic Acid API Market

  • 7.1 Overview
  • 7.2 North American Ursodeoxycholic Acid API Market by Type
  • 7.3 North American Ursodeoxycholic Acid API Market by Application
  • 7.4 United States Ursodeoxycholic Acid API Market
  • 7.5 Mexican Ursodeoxycholic Acid API Market
  • 7.6 Canadian Ursodeoxycholic Acid API Market

8. European Ursodeoxycholic Acid API Market

  • 8.1 Overview
  • 8.2 European Ursodeoxycholic Acid API Market by Type
  • 8.3 European Ursodeoxycholic Acid API Market by Application
  • 8.4 German Ursodeoxycholic Acid API Market
  • 8.5 French Ursodeoxycholic Acid API Market
  • 8.6 Spanish Ursodeoxycholic Acid API Market
  • 8.7 Italian Ursodeoxycholic Acid API Market
  • 8.8 United Kingdom Ursodeoxycholic Acid API Market

9. APAC Ursodeoxycholic Acid API Market

  • 9.1 Overview
  • 9.2 APAC Ursodeoxycholic Acid API Market by Type
  • 9.3 APAC Ursodeoxycholic Acid API Market by Application
  • 9.4 Japanese Ursodeoxycholic Acid API Market
  • 9.5 Indian Ursodeoxycholic Acid API Market
  • 9.6 Chinese Ursodeoxycholic Acid API Market
  • 9.7 South Korean Ursodeoxycholic Acid API Market
  • 9.8 Indonesian Ursodeoxycholic Acid API Market

10. ROW Ursodeoxycholic Acid API Market

  • 10.1 Overview
  • 10.2 ROW Ursodeoxycholic Acid API Market by Type
  • 10.3 ROW Ursodeoxycholic Acid API Market by Application
  • 10.4 Middle Eastern Ursodeoxycholic Acid API Market
  • 10.5 South American Ursodeoxycholic Acid API Market
  • 10.6 African Ursodeoxycholic Acid API Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Ursodeoxycholic Acid API Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 ICE
    • Company Overview
    • Ursodeoxycholic Acid API Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Mitsubishi Tanabe Pharma
    • Company Overview
    • Ursodeoxycholic Acid API Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Daewoong Chemical
    • Company Overview
    • Ursodeoxycholic Acid API Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 PharmaZell
    • Company Overview
    • Ursodeoxycholic Acid API Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Zhongshan Bailing
    • Company Overview
    • Ursodeoxycholic Acid API Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Dipharma Francis
    • Company Overview
    • Ursodeoxycholic Acid API Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Grindeks
    • Company Overview
    • Ursodeoxycholic Acid API Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Ursodeoxycholic Acid API Market
  • Figure 2.1: Usage of Ursodeoxycholic Acid API Market
  • Figure 2.2: Classification of the Global Ursodeoxycholic Acid API Market
  • Figure 2.3: Supply Chain of the Global Ursodeoxycholic Acid API Market
  • Figure 2.4: Driver and Challenges of the Ursodeoxycholic Acid API Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Ursodeoxycholic Acid API Market ($B) by Type
  • Figure 4.3: Forecast for the Global Ursodeoxycholic Acid API Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Synthetic UDCA in the Global Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Extraction UDCA in the Global Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 5.1: Global Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Ursodeoxycholic Acid API Market ($B) by Application
  • Figure 5.3: Forecast for the Global Ursodeoxycholic Acid API Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Pharmacy in the Global Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Health Products in the Global Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 6.1: Trends of the Global Ursodeoxycholic Acid API Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Ursodeoxycholic Acid API Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 7.2: North American Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 8.2: European Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
  • Figure 8.5: European Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 9.2: APAC Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Ursodeoxycholic Acid API Market (2019-2031)
  • Figure 10.2: ROW Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Ursodeoxycholic Acid API Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Ursodeoxycholic Acid API Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Ursodeoxycholic Acid API Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Ursodeoxycholic Acid API Market by Type
  • Figure 12.2: Growth Opportunities for the Global Ursodeoxycholic Acid API Market by Application
  • Figure 12.3: Growth Opportunities for the Global Ursodeoxycholic Acid API Market by Region
  • Figure 12.4: Emerging Trends in the Global Ursodeoxycholic Acid API Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Ursodeoxycholic Acid API Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Ursodeoxycholic Acid API Market by Region
  • Table 1.3: Global Ursodeoxycholic Acid API Market Parameters and Attributes
  • Table 3.1: Trends of the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 3.2: Forecast for the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Ursodeoxycholic Acid API Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 4.4: Trends of Synthetic UDCA in the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 4.5: Forecast for Synthetic UDCA in the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 4.6: Trends of Extraction UDCA in the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 4.7: Forecast for Extraction UDCA in the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Ursodeoxycholic Acid API Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 5.4: Trends of Pharmacy in the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 5.5: Forecast for Pharmacy in the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 5.6: Trends of Health Products in the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 5.7: Forecast for Health Products in the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Ursodeoxycholic Acid API Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Ursodeoxycholic Acid API Market (2025-2031)
  • Table 7.1: Trends of the North American Ursodeoxycholic Acid API Market (2019-2024)
  • Table 7.2: Forecast for the North American Ursodeoxycholic Acid API Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Ursodeoxycholic Acid API Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Ursodeoxycholic Acid API Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Ursodeoxycholic Acid API Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Ursodeoxycholic Acid API Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Ursodeoxycholic Acid API Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Ursodeoxycholic Acid API Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Ursodeoxycholic Acid API Market (2019-2031)
  • Table 8.1: Trends of the European Ursodeoxycholic Acid API Market (2019-2024)
  • Table 8.2: Forecast for the European Ursodeoxycholic Acid API Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Ursodeoxycholic Acid API Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Ursodeoxycholic Acid API Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Ursodeoxycholic Acid API Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Ursodeoxycholic Acid API Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Ursodeoxycholic Acid API Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Ursodeoxycholic Acid API Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Ursodeoxycholic Acid API Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Ursodeoxycholic Acid API Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Ursodeoxycholic Acid API Market (2019-2031)
  • Table 9.1: Trends of the APAC Ursodeoxycholic Acid API Market (2019-2024)
  • Table 9.2: Forecast for the APAC Ursodeoxycholic Acid API Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Ursodeoxycholic Acid API Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Ursodeoxycholic Acid API Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Ursodeoxycholic Acid API Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Ursodeoxycholic Acid API Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Ursodeoxycholic Acid API Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Ursodeoxycholic Acid API Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Ursodeoxycholic Acid API Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Ursodeoxycholic Acid API Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Ursodeoxycholic Acid API Market (2019-2031)
  • Table 10.1: Trends of the ROW Ursodeoxycholic Acid API Market (2019-2024)
  • Table 10.2: Forecast for the ROW Ursodeoxycholic Acid API Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Ursodeoxycholic Acid API Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Ursodeoxycholic Acid API Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Ursodeoxycholic Acid API Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Ursodeoxycholic Acid API Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Ursodeoxycholic Acid API Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Ursodeoxycholic Acid API Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Ursodeoxycholic Acid API Market (2019-2031)
  • Table 11.1: Product Mapping of Ursodeoxycholic Acid API Suppliers Based on Segments
  • Table 11.2: Operational Integration of Ursodeoxycholic Acid API Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Ursodeoxycholic Acid API Revenue
  • Table 12.1: New Product Launches by Major Ursodeoxycholic Acid API Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Ursodeoxycholic Acid API Market